TNF and rheumatoid arthritis: The introduction of anti–tumor necrosis factor (anti-TNF) biologic drugs in the clinical management of rheumatoid arthritis (RA) has proven highly successful in suppressing both inflammation and joint damage in many of the treated patients (1).